Literature DB >> 27068812

Enhanced Sensitivity of α3β4 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation.

Aravind R Gade1, Minho Kang1, Fayez Khan1, John R Grider1, M Imad Damaj1, William L Dewey1, Hamid I Akbarali2.   

Abstract

Opioid-induced constipation is a major side effect that persists with long-term opioid use. Previous studies demonstrated that nicotine-induced contractions are enhanced after long-term morphine exposure in guinea pig ileum. In the present study, we examined whether the increased sensitivity to nicotine could be observed in single enteric neurons after long-term morphine exposure, determined the subunits in mouse enteric neurons, and examined the effect of nicotine in reversing opioid-induced constipation. Nicotine (0.03-1 mM) dose-dependently induced inward currents from a holding potential of -60 mV in isolated single enteric neurons from the mouse ileum. The amplitude of the currents, but not the potency to nicotine, was significantly increased in neurons receiving long-term (16-24 h) but not short-term (10 min) exposure to morphine. Quantitative mRNA analysis showed that nicotinic acetylcholine receptor (nAChR) subunit expression in the mouse ileum was α3 ≥ β2 > β4 > α5 > α4 > β3 > α6. Nicotine-induced currents were obtained in neurons from α7, β2, α5, and α6 knockout mice. The currents were, however, inhibited by mecamylamine (10 μM) and the α3β4 blocker α-conotoxin AuIB (3 μM), suggesting that nicotine-induced currents were mediated by the α3β4 subtype of nAChRs on enteric neurons. Conversely, NS3861, a partial agonist at α3β4 nAChR, enhanced fecal pellet expulsion in a dose-dependent manner in mice that received long-term, but not short-term, morphine treatment. Overall, our findings suggest that the efficacy of nAChR agonists on enteric neurons is enhanced after long-term morphine exposure, and activation of the α3β4 subtype of nAChR reverses chronic, but not acute, morphine-induced constipation.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27068812      PMCID: PMC4885510          DOI: 10.1124/jpet.116.233304

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

Review 1.  Pharmacology of synaptic transmission in the enteric nervous system.

Authors:  James J Galligan
Journal:  Curr Opin Pharmacol       Date:  2002-12       Impact factor: 5.547

2.  Up-regulation of nicotinic receptors by nicotine varies with receptor subtype.

Authors:  Heather Walsh; Anitha P Govind; Ryan Mastro; J C Hoda; Daniel Bertrand; Yolanda Vallejo; William N Green
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

3.  Morphine dependence and withdrawal induced changes in cholinergic signaling.

Authors:  Nichole M Neugebauer; Emily B Einstein; Maria B Lopez; Tristan D McClure-Begley; Yann S Mineur; Marina R Picciotto
Journal:  Pharmacol Biochem Behav       Date:  2013-05-04       Impact factor: 3.533

4.  Opiate tolerance and dependence induced in vitro in single myenteric neurones.

Authors:  R A North; P J Karras
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

5.  Nicotine-induced up regulation of α4β2 neuronal nicotinic receptors is mediated by the protein kinase C-dependent phosphorylation of α4 subunits.

Authors:  L Wecker; V V Pollock; M A Pacheco; T Pastoor
Journal:  Neuroscience       Date:  2010-09-17       Impact factor: 3.590

6.  Morphine tolerance in the mouse ileum and colon.

Authors:  Gracious R Ross; Bichoy H Gabra; William L Dewey; Hamid I Akbarali
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

7.  alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.

Authors:  V Gerzanich; F Wang; A Kuryatov; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

Review 8.  Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

Authors:  Anitha P Govind; Paul Vezina; William N Green
Journal:  Biochem Pharmacol       Date:  2009-06-18       Impact factor: 5.858

9.  Morphine decreases enteric neuron excitability via inhibition of sodium channels.

Authors:  Tricia H Smith; John R Grider; William L Dewey; Hamid I Akbarali
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.

Authors:  S Luo; J M Kulak; G E Cartier; R B Jacobsen; D Yoshikami; B M Olivera; J M McIntosh
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

View more
  2 in total

1.  Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.

Authors:  Jessica C Young; Michele Jonsson Funk; Nabarun Dasgupta
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

2.  μ-Opioid Receptor-Mediated Enteric Glial Activation Is Involved in Morphine-Induced Constipation.

Authors:  Hui Gao; Yuxin Zhang; Yansong Li; Haiqing Chang; Bo Cheng; Na Li; Wei Yuan; Shuang Li; Qiang Wang
Journal:  Mol Neurobiol       Date:  2021-02-23       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.